In addition, FNDC3B, a membrane protein, not only promotes migration and invasion of glioma cells, but can also act as a prognostic biomarker (Fischer et al., 2017; Wang et al., 2020a). This evidence concerns the gene FNDC3B and central nervous system cancer.